Wockhardt gets US FDA nod for augmentin
MUMBAI (Reuters) - Wockhardt Ltd said on Thursday its U.S. subsidiary, Morton Grove Pharmaceuticals, received US FDA approval to market augmentin suspension, a pediatric drug.
The drug is used to treat several common infections, especially in children. The company intends to launch the product in the U.S in the third quarter of 2009, it said in a statement.
© Thomson Reuters 2009 All rights reserved
One Year Later
Mumbai's police paraded past some of the city's landmarks in a show of strength as the city marked the first anniversary of militant raids that killed 166 people Slideshow | Full Coverage
Liberhan Commission Report
The government published a long awaited report, recently leaked, accusing BJP leaders of a role in the 1992 destruction of the Babri mosque in Ayodhya. Full Article
